IBRAMVIBART
UNII PRC4J48944

Substance Identification & Data

This profile provides standardized clinical and technical data for Ibramvibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PRC4J48944.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3031270-42-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
PRC4J48944
CAS Registry Number
3031270-42-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
IBRAMVIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C215285
National Cancer Institute reference terminology for clinical and research data.
INN ID
13806
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ibramvibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IBRAMVIBART

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-454) (VH (HOMO SAPIENS IGHV3-21*07 (88.8%) -(IGHD) -IGHJ4*01 (92.9%), CDRIMGT (8.8.17) (26-33.51-58.97-113)) (1-124) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, 9-G1V78 CH3 L107 A114 (CH1 R120 (221) (125-222), HINGE 1-15 (223-237), CH2 (238-347), CH3 E12 (363), M14 (365), M107>L (435), N114>A (441) (348-452), CHS (453-454)) (125-454)), (227-217')-DISULFIDE WITH L-LAMBDA2 LIGHT CHAIN HOMO SAPIENS (1'-218') (VLAMBDA (HOMO SAPIENS IGLV1-40*01 (92.8%) -IGLJ1*01 (91.7%), CDR-IMGT (9.3.12) (26'-34'.52'-54'.91'-102')) (1'-112') -HOMO SAPIENS IGLC2*01 (100%) (C-LAMBDA2) (113'-218')); DIMER (233-233'':236-236'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA
IBRAMVIBART [INN]
IMMUNOGLOBULIN G1 (435-LEUCINE,441-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL VYD2311 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VYD2311 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) PROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY (IBRAMVIBART)

Technical Codes

VYD2311
VYD-2311

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus